Financials
Financial year 2025
HMD Pharma Consultancy from Sint-Jans-Molenbeek, company number BE1013637627, closed financial year 2025 with a result of € 73,006 after tax. For that financial year HMD Pharma Consultancy recorded a gross margin of € 74,164 and equity of € 75,006. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 1, 2026.
€ 75,006
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 73,006
Profit after tax over the fiscal year.
€ 48,377
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 73,006.
People and assets in 2025
€ 25,645
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 425
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to HMD Pharma Consultancy?
What happened at HMD Pharma Consultancy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 73,006. filed late Source: NBB ↗
- New establishment in Sint-Jans-Molenbeek. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at HMD Pharma Consultancy? We notify you, reason included.
Follow HMD Pharma ConsultancyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Piersstraat 27
1080 Sint-Jans-Molenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1013.637.627
- VAT number
- BE 1013.637.627
- Registered office
- Piersstraat 27, 1080 Sint-Jans-Molenbeek
- Names & denominations
- HMD Pharma Consultancy
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 September 2024
- Peppol
- Active · Active since 15 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten op het gebied van voeding
Detailhandel in cosmetica en toiletartikelen
Overige zakelijke dienstverlening, neg
Overige menselijke gezondheidszorg, n.e.g.
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering